Merus N.V. (MRUS)
NASDAQ: MRUS · Real-Time Price · USD
57.04
+1.03 (1.84%)
Jun 6, 2025, 1:55 PM - Market open
Merus Employees
As of December 31, 2024, Merus had 321 total employees, including 260 full-time and 61 part-time employees. The number of employees increased by 92 or 40.17% compared to the previous year.
Employees
321
Change (1Y)
92
Growth (1Y)
40.17%
Revenue / Employee
$170,505
Profits / Employee
-$864,000
Market Cap
3.95B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
MRUS News
- 2 days ago - Merus N.V. Announces Pricing of Public Offering of Common Shares - GlobeNewsWire
- 2 days ago - Merus N.V. Announces Proposed Public Offering of Common Shares - GlobeNewsWire
- 10 days ago - Merus to Present at Upcoming Investor Conferences - GlobeNewsWire
- 14 days ago - Merus' Petosemtamab with Pembrolizumab Interim Data Demonstrates Robust Efficacy and Durability in 1L PD-L1+ r/m HNSCC - GlobeNewsWire
- 22 days ago - Merus Announces the Journal Publication of Petosemtamab Mechanism of Action - GlobeNewsWire
- 4 weeks ago - Merus to Present at BofA Securities 2025 Health Care Conference - GlobeNewsWire
- 4 weeks ago - Merus Announces Financial Results for the First Quarter 2025 and Provides Business Update - GlobeNewsWire
- 6 weeks ago - Merus Announces Abstract Accepted for Presentation at the 2025 ASCO® Annual Meeting - GlobeNewsWire